Literature DB >> 23965433

The development of a sensitive methodology to characterise hard shell capsule puncture by dry powder inhaler pins.

Barbara M Torrisi1, James C Birchall, Brian E Jones, Fernando Díez, Sion A Coulman.   

Abstract

In order for hard-shell capsules to function effectively as drug reservoirs in dry powder inhalers, the capsule must be punctured with sharpened pins to release the powdered medicament upon inspiration. Capsule performance in this setting is poorly understood. This study aims to develop a methodology to characterise hard shell capsule penetration by needles from commercial dry powder inhalers, to determine whether changes to capsule materials impact on their performance. Two pin types from two commercial dry powder inhalers were mounted in a material-testing machine, equipped with a 500 N load cell. A stainless steel bush was used to secure a capsule directly below the steel pin. Hypromellose (n=10) and gelatin capsules (n=10) were conditioned in 'normal' or low humidity conditions and were subsequently punctured with both types of pin. Each puncture event was recorded on a load-displacement curve. The force required for puncture was 2.82±0.26 N for hypromellose capsules and 4.54±0.26 N for gelatin capsules, stored in normal humidity. Different capsule materials possessed distinguishable signature profiles but repeated force-displacement profiles were highly reproducible i.e. intra-individual variability was minimal. A rapid, robust yet sensitive methodology has therefore been developed that is able to characterise hard shell capsule materials based on the puncture performance.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Capsule; Dry powder inhaler; Gelatin; Hypromellose; Puncture

Mesh:

Substances:

Year:  2013        PMID: 23965433     DOI: 10.1016/j.ijpharm.2013.08.011

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery.

Authors:  Kena Zhao; Tao Guo; Caifen Wang; Yong Zhou; Ting Xiong; Li Wu; Xue Li; Priyanka Mittal; Senlin Shi; Ruxandra Gref; Jiwen Zhang
Journal:  Acta Pharm Sin B       Date:  2020-05-07       Impact factor: 11.413

2.  Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations.

Authors:  Li Ding; Ashlee D Brunaugh; Rishi Thakkar; Christian Lee; Qingyan Jenny Zhao; Justin Kalafat; Mohammed Maniruzzaman; Hugh D C Smyth
Journal:  AAPS PharmSciTech       Date:  2022-01-11       Impact factor: 4.026

3.  Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types.

Authors:  Edit Benke; Patrícia Varga; Piroska Szabó-Révész; Rita Ambrus
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.